These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 8732167)
1. Novel, high expressing and antibiotic-controlled plasmid vectors designed for use in gene therapy. Liang X; Hartikka J; Sukhu L; Manthorpe M; Hobart P Gene Ther; 1996 Apr; 3(4):350-6. PubMed ID: 8732167 [TBL] [Abstract][Full Text] [Related]
2. Highly controlled gene expression using combinations of a tissue-specific promoter, recombinant adenovirus and a tetracycline-regulatable transcription factor. Ghersa P; Gobert RP; Sattonnet-Roche P; Richards CA; Merlo Pich E; Hooft van Huijsduijnen R Gene Ther; 1998 Sep; 5(9):1213-20. PubMed ID: 9930322 [TBL] [Abstract][Full Text] [Related]
3. A novel doxycycline inducible autoregulatory plasmid which displays "on"/"off" regulation suited to gene therapy applications. Gould DJ; Berenstein M; Dreja H; Ledda F; Podhajcer OL; Chernajovsky Y Gene Ther; 2000 Dec; 7(24):2061-70. PubMed ID: 11223986 [TBL] [Abstract][Full Text] [Related]
4. Selection and characterization of a promoter for expression of single-copy recombinant genes in Gram-positive bacteria. Provvedi R; Maggi T; Oggioni MR; Manganelli R; Pozzi G BMC Biotechnol; 2005 Jan; 5():3. PubMed ID: 15651989 [TBL] [Abstract][Full Text] [Related]
5. Doxycycline- and tetracycline-regulated transcriptional silencer enhance the expression level and transactivating performance of rtTA. Lai JF; Cheng HY; Cheng TL; Lin YY; Chen LC; Lin MT; Jou TS J Gene Med; 2004 Dec; 6(12):1403-13. PubMed ID: 15523716 [TBL] [Abstract][Full Text] [Related]
6. Activator protein 1-mediated transcriptional regulation strategy sustains long-term expression of a xenogeneic gene product in vivo: an implication for gene therapy targeting congenital protein deficiencies. Sasaki S; Smith JM; Takase K; Okuda K; Ishii N; Takeshita F Int J Mol Med; 2006 Aug; 18(2):289-97. PubMed ID: 16820937 [TBL] [Abstract][Full Text] [Related]
7. A set of vectors with a tetracycline-regulatable promoter system for modulated gene expression in Saccharomyces cerevisiae. Garí E; Piedrafita L; Aldea M; Herrero E Yeast; 1997 Jul; 13(9):837-48. PubMed ID: 9234672 [TBL] [Abstract][Full Text] [Related]
8. High and sustained transgene expression in vivo from plasmid vectors containing a hybrid ubiquitin promoter. Yew NS; Przybylska M; Ziegler RJ; Liu D; Cheng SH Mol Ther; 2001 Jul; 4(1):75-82. PubMed ID: 11472109 [TBL] [Abstract][Full Text] [Related]
9. Efficient control of gene expression by single step integration of the tetracycline system in transgenic mice. Schultze N; Burki Y; Lang Y; Certa U; Bluethmann H Nat Biotechnol; 1996 Apr; 14(4):499-503. PubMed ID: 9630928 [TBL] [Abstract][Full Text] [Related]
10. A tetracycline controlled activation/repression system with increased potential for gene transfer into mammalian cells. Freundlieb S; Schirra-Müller C; Bujard H J Gene Med; 1999; 1(1):4-12. PubMed ID: 10738580 [TBL] [Abstract][Full Text] [Related]
11. Homogeneity and long-term stability of tetracycline-regulated gene expression with low basal activity by using the rtTA2S-M2 transactivator and insulator-flanked reporter vectors. Qu Z; Thottassery JV; Van Ginkel S; Manuvakhova M; Westbrook L; Roland-Lazenby C; Hays S; Kern FG Gene; 2004 Feb; 327(1):61-73. PubMed ID: 14960361 [TBL] [Abstract][Full Text] [Related]
12. New complex Ad vectors incorporating both rtTA and tTS deliver tightly regulated transgene expression both in vitro and in vivo. Rubinchik S; Woraratanadharm J; Yu H; Dong JY Gene Ther; 2005 Mar; 12(6):504-11. PubMed ID: 15660114 [TBL] [Abstract][Full Text] [Related]
13. Improved broad-host-range RK2 vectors useful for high and low regulated gene expression levels in gram-negative bacteria. Blatny JM; Brautaset T; Winther-Larsen HC; Karunakaran P; Valla S Plasmid; 1997; 38(1):35-51. PubMed ID: 9281494 [TBL] [Abstract][Full Text] [Related]
14. Generation and characterization of tTS-H4: a novel transcriptional repressor that is compatible with the reverse tetracycline-controlled TET-ON system. Bockamp E; Christel C; Hameyer D; Khobta A; Maringer M; Reis M; Heck R; Cabezas-Wallscheid N; Epe B; Oesch-Bartlomowicz B; Kaina B; Schmitt S; Eshkind L J Gene Med; 2007 Apr; 9(4):308-18. PubMed ID: 17330923 [TBL] [Abstract][Full Text] [Related]
16. Increased level and duration of expression in muscle by co-expression of a transactivator using plasmid systems. Li S; MacLaughlin FC; Fewell JG; Li Y; Mehta V; French MF; Nordstrom JL; Coleman M; Belagali NS; Schwartz RJ; Smith LC Gene Ther; 1999 Dec; 6(12):2005-11. PubMed ID: 10637452 [TBL] [Abstract][Full Text] [Related]
17. Integration-proficient plasmids for Pseudomonas aeruginosa: site-specific integration and use for engineering of reporter and expression strains. Hoang TT; Kutchma AJ; Becher A; Schweizer HP Plasmid; 2000 Jan; 43(1):59-72. PubMed ID: 10610820 [TBL] [Abstract][Full Text] [Related]
18. Autoregulated multicistronic expression vectors provide one-step cloning of regulated product gene expression in mammalian cells. Fussenegger M; Moser S; Mazur X; Bailey JE Biotechnol Prog; 1997; 13(6):733-40. PubMed ID: 9413131 [TBL] [Abstract][Full Text] [Related]
19. Efficient gene transfer into zebrafish skeletal muscle by intramuscular injection of plasmid DNA. Tan JH; Chan WK Mol Mar Biol Biotechnol; 1997 Jun; 6(2):98-109. PubMed ID: 9200836 [TBL] [Abstract][Full Text] [Related]
20. Tight control of transgene expression by lentivirus vectors containing second-generation tetracycline-responsive promoters. Pluta K; Luce MJ; Bao L; Agha-Mohammadi S; Reiser J J Gene Med; 2005 Jun; 7(6):803-17. PubMed ID: 15655804 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]